Donga Socio Holdings
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of S… Read more
Donga Socio Holdings (000640) - Net Assets
Latest net assets as of September 2025: ₩1.16 Trillion KRW
Based on the latest financial reports, Donga Socio Holdings (000640) has net assets worth ₩1.16 Trillion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩2.13 Trillion) and total liabilities (₩974.23 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩1.16 Trillion |
| % of Total Assets | 54.28% |
| Annual Growth Rate | 7.04% |
| 5-Year Change | 19.72% |
| 10-Year Change | 76.55% |
| Growth Volatility | 19.93 |
Donga Socio Holdings - Net Assets Trend (2000–2024)
This chart illustrates how Donga Socio Holdings's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Donga Socio Holdings (2000–2024)
The table below shows the annual net assets of Donga Socio Holdings from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩1.06 Trillion | +3.57% |
| 2023-12-31 | ₩1.03 Trillion | +2.87% |
| 2022-12-31 | ₩998.66 Billion | +1.38% |
| 2021-12-31 | ₩985.04 Billion | +10.84% |
| 2020-12-31 | ₩888.72 Billion | +18.99% |
| 2019-12-31 | ₩746.90 Billion | +1.51% |
| 2018-12-31 | ₩735.76 Billion | -19.52% |
| 2017-12-31 | ₩914.25 Billion | +4.38% |
| 2016-12-31 | ₩875.86 Billion | +45.34% |
| 2015-12-31 | ₩602.64 Billion | +12.75% |
| 2014-12-31 | ₩534.48 Billion | +3.86% |
| 2013-12-31 | ₩514.60 Billion | -41.60% |
| 2012-12-31 | ₩881.24 Billion | +2.19% |
| 2011-12-31 | ₩862.39 Billion | +15.66% |
| 2010-12-31 | ₩745.61 Billion | +28.48% |
| 2009-12-31 | ₩580.35 Billion | +65.37% |
| 2008-12-31 | ₩350.94 Billion | +6.77% |
| 2007-12-31 | ₩328.69 Billion | +2.86% |
| 2006-12-31 | ₩319.55 Billion | -7.17% |
| 2005-12-31 | ₩344.22 Billion | +12.18% |
| 2004-12-31 | ₩306.84 Billion | +15.04% |
| 2003-12-31 | ₩266.72 Billion | +21.50% |
| 2002-12-31 | ₩219.52 Billion | +15.01% |
| 2001-12-31 | ₩190.87 Billion | -8.26% |
| 2000-12-31 | ₩208.05 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Donga Socio Holdings's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 96577.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩773.42 Billion | 73.69% |
| Other Components | ₩276.19 Billion | 26.31% |
| Total Equity | ₩1.05 Trillion | 100.00% |
Donga Socio Holdings Competitors by Market Cap
The table below lists competitors of Donga Socio Holdings ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zhejiang Sf Oilless Bearing Co Ltd
SHE:300817
|
$206.35 Million |
|
TAIDOC TECHNOLOGY CORP
TW:4736
|
$206.41 Million |
|
Netronix
TWO:6143
|
$206.42 Million |
|
CPH Group AG
F:1L6
|
$206.45 Million |
|
Ce Link Ltd
SHE:300787
|
$206.34 Million |
|
OVH GROUPE (PROM.)EO 1
F:7U7
|
$206.34 Million |
|
Spok Holdings Inc
NASDAQ:SPOK
|
$206.30 Million |
|
Indo Count Industries Limited
NSE:ICIL
|
$206.29 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Donga Socio Holdings's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,012,471,183,440 to 1,049,611,141,120, a change of 37,139,957,680 (3.7%).
- Net income of 58,022,061,470 contributed positively to equity growth.
- Dividend payments of 11,876,373,700 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩58.02 Billion | +5.53% |
| Dividends Paid | ₩11.88 Billion | -1.13% |
| Other Changes | ₩-9.01 Billion | -0.86% |
| Total Change | ₩- | 3.67% |
Book Value vs Market Value Analysis
This analysis compares Donga Socio Holdings's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.64x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩148699.82 | ₩104000.00 | x |
| 2018-12-31 | ₩119608.83 | ₩104000.00 | x |
| 2019-12-31 | ₩121392.22 | ₩104000.00 | x |
| 2020-12-31 | ₩146720.89 | ₩104000.00 | x |
| 2021-12-31 | ₩154442.42 | ₩104000.00 | x |
| 2022-12-31 | ₩152524.35 | ₩104000.00 | x |
| 2023-12-31 | ₩161976.65 | ₩104000.00 | x |
| 2024-12-31 | ₩163027.55 | ₩104000.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Donga Socio Holdings utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.53%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.35%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 1.93x
- Recent ROE (5.53%) is below the historical average (7.72%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 11.20% | 4.62% | 0.85x | 2.83x | ₩2.31 Billion |
| 2001 | 12.69% | 4.24% | 0.94x | 3.17x | ₩5.02 Billion |
| 2002 | 20.71% | 7.33% | 1.05x | 2.70x | ₩23.43 Billion |
| 2003 | 9.01% | 2.76% | 1.05x | 3.12x | ₩-2.20 Billion |
| 2004 | 10.16% | 3.39% | 1.11x | 2.69x | ₩413.15 Million |
| 2005 | 8.45% | 3.42% | 1.03x | 2.41x | ₩-4.67 Billion |
| 2007 | 10.60% | 5.06% | 0.96x | 2.18x | ₩1.97 Billion |
| 2008 | 12.39% | 5.68% | 0.99x | 2.20x | ₩8.35 Billion |
| 2009 | 10.91% | 7.30% | 0.82x | 1.82x | ₩5.26 Billion |
| 2010 | 10.10% | 7.77% | 0.77x | 1.69x | ₩704.62 Million |
| 2011 | 8.39% | 6.56% | 0.71x | 1.81x | ₩-13.32 Billion |
| 2012 | 10.12% | 7.76% | 0.64x | 2.03x | ₩992.28 Million |
| 2013 | 3.30% | 2.73% | 0.58x | 2.10x | ₩-31.59 Billion |
| 2014 | 0.35% | 0.27% | 0.58x | 2.23x | ₩-46.86 Billion |
| 2015 | 9.18% | 6.79% | 0.58x | 2.35x | ₩-4.28 Billion |
| 2016 | 17.02% | 20.53% | 0.52x | 1.60x | ₩61.47 Billion |
| 2017 | 3.57% | 4.71% | 0.47x | 1.60x | ₩-58.73 Billion |
| 2018 | -22.33% | -23.19% | 0.57x | 1.69x | ₩-237.40 Billion |
| 2019 | 2.65% | 2.57% | 0.57x | 1.82x | ₩-54.75 Billion |
| 2020 | 18.27% | 20.73% | 0.52x | 1.70x | ₩73.47 Billion |
| 2021 | 6.24% | 6.83% | 0.52x | 1.75x | ₩-36.25 Billion |
| 2022 | 1.14% | 1.10% | 0.59x | 1.76x | ₩-87.05 Billion |
| 2023 | 5.73% | 5.12% | 0.58x | 1.93x | ₩-43.26 Billion |
| 2024 | 5.53% | 4.35% | 0.66x | 1.93x | ₩-46.94 Billion |
Industry Comparison
This section compares Donga Socio Holdings's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $169,660,285,933
- Average return on equity (ROE) among peers: 0.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Donga Socio Holdings (000640) | ₩1.16 Trillion | 11.20% | 0.84x | $206.35 Million |
| Dongwha Pharm.Co.Ltd (000020) | $229.73 Billion | 2.15% | 0.36x | $75.32 Million |
| Yuhan Corp. (000100) | $323.58 Billion | 10.19% | 0.72x | $4.21 Billion |
| Yuyu Pharma Inc (000227) | $128.69 Billion | -1.72% | 0.50x | $26.44 Million |
| Ildong Holdings Co Ltd (000230) | $66.98 Billion | 10.88% | 1.80x | $49.55 Million |
| Samil Pharm (000520) | $62.87 Billion | 0.00% | 0.77x | $110.58 Million |
| Jw Pharmac (001060) | $223.83 Billion | 0.28% | 1.65x | $278.34 Million |
| JW Pharmaceutical Corp (001067) | $265.44 Billion | 13.94% | 1.43x | $489.75 Million |
| Samsung Pharm (001360) | $77.58 Billion | -31.98% | 0.20x | $65.82 Million |
| Ahn-Gook Pharmaceutical Co. Ltd (001540) | $148.25 Billion | 1.71% | 0.47x | $27.39 Million |